BioForce Nanosciences (OTCMKTS:BFNH) Releases Quarterly Earnings Results

BioForce Nanosciences (OTCMKTS:BFNH) issued its quarterly earnings results on Tuesday. The company reported ($0.01) earnings per share for the quarter, Zacks reports.

BioForce Nanosciences Price Performance

OTCMKTS:BFNH opened at $0.57 on Thursday. The company has a market cap of $19.04 million, a price-to-earnings ratio of -56.79 and a beta of -0.89. The stock’s 50 day simple moving average is $0.57 and its two-hundred day simple moving average is $0.80. BioForce Nanosciences has a 1 year low of $0.16 and a 1 year high of $2.07.

BioForce Nanosciences Company Profile

BioForce Nanosciences Holdings, Inc focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www.bioforceeclipse.com, as well as through social media and telemarketing channels.